IL326433A - מעכבי irak4 גבישיים - Google Patents
מעכבי irak4 גבישייםInfo
- Publication number
- IL326433A IL326433A IL326433A IL32643326A IL326433A IL 326433 A IL326433 A IL 326433A IL 326433 A IL326433 A IL 326433A IL 32643326 A IL32643326 A IL 32643326A IL 326433 A IL326433 A IL 326433A
- Authority
- IL
- Israel
- Prior art keywords
- crystalline
- irak4 inhibitors
- irak4
- inhibitors
- crystalline irak4
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23191039 | 2023-08-11 | ||
| PCT/EP2024/072595 WO2025036841A1 (en) | 2023-08-11 | 2024-08-09 | Crystalline irak4 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326433A true IL326433A (he) | 2026-04-01 |
Family
ID=87571270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326433A IL326433A (he) | 2023-08-11 | 2024-08-09 | מעכבי irak4 גבישיים |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN121773099A (he) |
| AU (1) | AU2024323545A1 (he) |
| IL (1) | IL326433A (he) |
| MX (1) | MX2026001674A (he) |
| WO (1) | WO2025036841A1 (he) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3126330T3 (en) | 2014-04-04 | 2019-04-23 | Pfizer | BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS |
| TW201701879A (zh) | 2015-04-30 | 2017-01-16 | 拜耳製藥公司 | Ｉｒａｋ４抑制劑組合 |
| CN108024971A (zh) | 2015-07-15 | 2018-05-11 | 奥列基因发现技术有限公司 | 作为irak-4抑制剂的取代的氮杂化合物 |
| SG10202011653WA (en) | 2016-06-01 | 2020-12-30 | Bayer Pharma AG | Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseases |
| EP3642201A1 (en) | 2017-06-21 | 2020-04-29 | H. Hoffnabb-La Roche Ag | Isoindolinone derivatives as irak4 modulators |
| US20230002361A1 (en) * | 2019-06-27 | 2023-01-05 | Biogen Ma Inc. | 2h-indazole derivatives and their use in the treatment of disease |
| JP7555519B2 (ja) | 2022-02-14 | 2024-09-24 | アストラゼネカ・アクチエボラーグ | Ｉｒａｋ４阻害剤 |
-
2024
- 2024-08-09 CN CN202480052516.2A patent/CN121773099A/zh active Pending
- 2024-08-09 WO PCT/EP2024/072595 patent/WO2025036841A1/en active Pending
- 2024-08-09 IL IL326433A patent/IL326433A/he unknown
- 2024-08-09 AU AU2024323545A patent/AU2024323545A1/en active Pending
-
2026
- 2026-02-10 MX MX2026001674A patent/MX2026001674A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025036841A1 (en) | 2025-02-20 |
| CN121773099A (zh) | 2026-03-31 |
| AU2024323545A1 (en) | 2026-03-26 |
| MX2026001674A (es) | 2026-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202107225SA (en) | Crystalline form of a cdk inhibitor | |
| IL316075A (he) | צורה גבישית של לניפיברנור | |
| IL314049A (he) | מעכבי parp7 | |
| IL316450A (he) | תרכובות לעיכוב kif18a | |
| GB202008201D0 (en) | Inhibitor compounds | |
| GB202102360D0 (en) | Crystalline compound | |
| IL289929A (he) | צורות גבישיות של מעכב cd73 | |
| IL320185A (he) | תרכובת הטרוציקלית | |
| IL320747A (he) | נגזרות פיפרידין כמעקבי 3mettl | |
| GB202004960D0 (en) | Inhibitor compounds | |
| IL318955A (he) | תרכובות פירידינון מותמר כמעכבי cbl-b | |
| IL321171A (he) | צורות גבישיות של 2-אוקסוקווינאזולין | |
| IL317105A (he) | מעכבי par-2 חדשים | |
| GB202300881D0 (en) | Inhibitor compounds | |
| IL314800A (he) | מעכבי irak4 | |
| IL326433A (he) | מעכבי irak4 גבישיים | |
| IL325727A (he) | צורה גבישית | |
| CA3301339A1 (en) | Crystalline irak4 inhibitors | |
| GB202307924D0 (en) | Inhibitor compounds | |
| HK40120257A (en) | Irak4 inhibitors | |
| GB202217726D0 (en) | Crystalline compound | |
| IL317047A (he) | צורות מוצקות של הטרוציקלילאמידים כמעכבי irak4 | |
| CA3293096A1 (en) | Processes for making irak4 inhibitors | |
| HK40080052A (en) | Crystalline ret inhibitor | |
| IL320219A (he) | מעכבים |